Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Organisation › Details

Novimmune S.A.

Novimmune SA is a privately held, Swiss biopharmaceutical company focused on the discovery and development of antibody-based medicines for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer. The company is headquartered in Geneva and runs a Clinical and Commercial Development Center in Basel. The company currently employs 130 people. *

 

Period Start 1998-01-01 established
Products Industry therapeutic antibody
  Industry 2 bispecific antibody
Persons Person Holdener, Eduard (Ed) (Novimmune 201512– CEO before Roche CMO)
  Person 2 Bolliger, Luca (Novimmune 201012 Director Business Development + Communication)
     
Region Region Plan-les-Ouates GE
  Country Switzerland
  Street 14 Chemin des Aulx
  City 1228 Plan-les-Ouates GE
  Tel +41-22-839-7141
    Address record changed: 2018-07-24
     
Basic data Employees D: 101 to 500 (2017-07-18)
     
    * Document for �About Section�: Novimmune S.A.. (7/18/17). "Press Release: Novimmune and Shire Sign License Agreement Deepening Bispecific Antibody Research Collaboration". Geneva.
     
   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Novimmune S.A.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top